Back to Search
Start Over
Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy.
- Source :
- Leukemia & Lymphoma; May2017, Vol. 58 Issue 5, p1227-1230, 4p
- Publication Year :
- 2017
-
Abstract
- The article discusses a randomized phase-two study which determines whether changes in nuclear factor kappa B (NF-ƘB) activity corresponded with changes in the expression of NF-ƘB target genes. In the said study, the newly diagnosed patients with acute myelogenous leukemia (AML) eligible for standard induction chemotherapy were assigned to choline magnesium trisalicylate (CMT) or no CMT.
Details
- Language :
- English
- ISSN :
- 10428194
- Volume :
- 58
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Leukemia & Lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 121234902
- Full Text :
- https://doi.org/10.1080/10428194.2016.1225206